Urologix (ULGX +27%) soars MDT)">after announcing it's signed an exclusive worldwide license to...

|By:, SA News Editor

Urologix (OTCPK:ULGX +27%) soars after announcing it's signed an exclusive worldwide license to manufacture and market Medtronic's (MDT +0.2%) Prostiva RF Therapy System for the treatment of BPH.